Saturday, 25 December 2010

Algioxib




Algioxib may be available in the countries listed below.


Ingredient matches for Algioxib



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Algioxib in the following countries:


  • Argentina

International Drug Name Search

Phenazepam




CAS registry number (Chemical Abstracts Service)

0051753-57-2

Chemical Formula

C15-H10-Br-Cl-N2-O

Molecular Weight

349

Therapeutic Categories

Anxiolytic agent

Benzodiazepine derivative

Anticonvulsant agent

Chemical Names

2H-1,4-Benzodiazepin-2-one, 7-bromo-5-(2-chlorophenyl)-

2H-1,4-Benzodiazepin-2-one, 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-

7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on (IUPAC)

7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one

Foreign Name

  • Fenazepam (German)

Generic Names

  • 5-24-04-00341 (IS: Beilstein)
  • BD 98 (IS)
  • BRN 0889456 (IS)

Brand Name

  • Fenazepam
    Olainfarm, Latvia

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 12 December 2010

Calcium (aminosalicylate de)




Calcium (aminosalicylate de) may be available in the countries listed below.


Ingredient matches for Calcium (aminosalicylate de)



Aminosalicylic Acid

Calcium (aminosalicylate de) (DCF) is known as Aminosalicylic Acid in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 9 December 2010

Azathioprin beta




Azathioprin beta may be available in the countries listed below.


Ingredient matches for Azathioprin beta



Azathioprine

Azathioprine is reported as an ingredient of Azathioprin beta in the following countries:


  • Germany

International Drug Name Search

Citalopram 1A Farma




Citalopram 1A Farma may be available in the countries listed below.


Ingredient matches for Citalopram 1A Farma



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram 1A Farma in the following countries:


  • Denmark

International Drug Name Search

Tuesday, 7 December 2010

Aflamax




Aflamax may be available in the countries listed below.


Ingredient matches for Aflamax



Naproxen

Naproxen is reported as an ingredient of Aflamax in the following countries:


  • Peru

Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Aflamax in the following countries:


  • Peru

International Drug Name Search

Sunday, 5 December 2010

Dalmadorm medium




Dalmadorm medium may be available in the countries listed below.


Ingredient matches for Dalmadorm medium



Flurazepam

Flurazepam monohydrochloride (a derivative of Flurazepam) is reported as an ingredient of Dalmadorm medium in the following countries:


  • Iceland

International Drug Name Search

Ketoson




Ketoson may be available in the countries listed below.


Ingredient matches for Ketoson



Ketoconazole

Ketoconazole is reported as an ingredient of Ketoson in the following countries:


  • Sweden

International Drug Name Search

Saturday, 27 November 2010

Etacid




Etacid may be available in the countries listed below.


Ingredient matches for Etacid



Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Etacid in the following countries:


  • Georgia

International Drug Name Search

Thursday, 25 November 2010

Altraz




Altraz may be available in the countries listed below.


Ingredient matches for Altraz



Anastrozole

Anastrozole is reported as an ingredient of Altraz in the following countries:


  • India

International Drug Name Search

Sunday, 21 November 2010

Acido Pipemidico EG




Acido Pipemidico EG may be available in the countries listed below.


Ingredient matches for Acido Pipemidico EG



Pipemidic Acid

Pipemidic Acid is reported as an ingredient of Acido Pipemidico EG in the following countries:


  • Italy

International Drug Name Search

Friday, 19 November 2010

Fluoxetine Lannacher




Fluoxetine Lannacher may be available in the countries listed below.


Ingredient matches for Fluoxetine Lannacher



Fluoxetine

Fluoxetine is reported as an ingredient of Fluoxetine Lannacher in the following countries:


  • Lithuania

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetine Lannacher in the following countries:


  • Latvia

  • Russian Federation

International Drug Name Search

Piperacilline / Tazobactam Mylan




Piperacilline / Tazobactam Mylan may be available in the countries listed below.


Ingredient matches for Piperacilline / Tazobactam Mylan



Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Piperacilline / Tazobactam Mylan in the following countries:


  • Netherlands

Tazobactam

Tazobactam sodium salt (a derivative of Tazobactam) is reported as an ingredient of Piperacilline / Tazobactam Mylan in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 16 November 2010

Propetamphos




In some countries, this medicine may only be approved for veterinary use.

Scheme

BAN

CAS registry number (Chemical Abstracts Service)

0031218-83-4

Chemical Formula

C10-H20-N-O4-P-S

Molecular Weight

281

Therapeutic Category

Antiparasitic agent

Chemical Names

(E)-3-[[(Ethylamino)methoxyphosphinothioyl]-oxy]-2-butenoic acid 1-methylethyl ester

(E)-3-Hydroxycrotonic acid isopropyl ester, O-ester with O-methyl ethylphosphoramidothioate

(E)-Isopropyl 3-[ethylamino(methoxy)thiophosphoryloxy]crotonat (IUPAC)

Isopropyl (E)-3-[(ethylamino)(methyoxy)phosphinothioyloxy]but-2-enoate (BAN)

Foreign Name

  • Propetamphos (German)

Generic Names

  • Propetamphos (OS: BAN)
  • Blotic (IS)
  • Caswell No. 706A (IS)
  • EPA Pesticide Chemical Code 113601 (IS)
  • Gardecto (IS)
  • HSDB 6985 (IS)
  • OMS 1502 (IS)
  • Paratikan (IS)
  • Safrotin S 200 (IS)
  • SAN 3221 (IS)
  • VEL 4283 (IS)

Brand Names

  • Collier antiparasitaire Clément-Thékan (veterinary use)
    Omega Pharma France, France


  • PAB NF (veterinary use)
    Bayer Animal Health, South Africa


  • Seraphos (veterinary use)
    Bayer Animal, New Zealand


  • Young's Ectomort Sheep Dip (veterinary use)
    Cypharm, Ireland

International Drug Name Search

Glossary

BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 7 November 2010

Flexmed




Flexmed may be available in the countries listed below.


Ingredient matches for Flexmed



Cetirizine

Cetirizine is reported as an ingredient of Flexmed in the following countries:


  • Peru

International Drug Name Search

Wednesday, 3 November 2010

Progestérone




Progestérone may be available in the countries listed below.


Ingredient matches for Progestérone



Progesterone

Progestérone (DCF) is known as Progesterone in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Citocartin




Citocartin may be available in the countries listed below.


Ingredient matches for Citocartin



Articaine

Articaine hydrochloride (a derivative of Articaine) is reported as an ingredient of Citocartin in the following countries:


  • Italy

  • Poland

Epinephrine

Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Citocartin in the following countries:


  • Italy

Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of Citocartin in the following countries:


  • Poland

International Drug Name Search

Wednesday, 27 October 2010

Urdex




Urdex may be available in the countries listed below.


Ingredient matches for Urdex



Ursodeoxycholic Acid

Ursodeoxycholic Acid is reported as an ingredient of Urdex in the following countries:


  • Japan

International Drug Name Search

Tuesday, 26 October 2010

Cepodem




Cepodem may be available in the countries listed below.


Ingredient matches for Cepodem



Cefpodoxime

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Cepodem in the following countries:


  • Bahrain

  • China

  • India

  • Myanmar

  • Poland

  • South Africa

  • Sri Lanka

International Drug Name Search

Wednesday, 20 October 2010

Dojilon




Dojilon may be available in the countries listed below.


Ingredient matches for Dojilon



Prednisolone

Prednisolone 21-(disodium phosphate) (a derivative of Prednisolone) is reported as an ingredient of Dojilon in the following countries:


  • Japan

International Drug Name Search

Friday, 15 October 2010

Detrol LA


See also: Generic Detrol


Detrol LA is a brand name of tolterodine, approved by the FDA in the following formulation(s):


DETROL LA (tolterodine tartrate - capsule, extended release; oral)



  • Manufacturer: PHARMACIA AND UPJOHN

    Approval date: December 22, 2000

    Strength(s): 2MG, 4MG [RLD]

Has a generic version of Detrol LA been approved?


No. There is currently no therapeutically equivalent version of Detrol LA available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Detrol LA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • 3,3-diphenylpropylamines and pharmaceutical compositions thereof
    Patent 5,382,600
    Issued: January 17, 1995
    Inventor(s): Jonsson; Nils A. & Sparf; Bengt A. & Mikiver; Lembit & Moses; Pinchas & Nilvebrant; Lisbet & Glas; Gunilla
    Assignee(s): Pharmacia Aktiebolag
    ##STR1## Novel 3,3-diphenylpropylamines of formula (I) wherein R.sup.1 signifies hydrogen or methyl, R.sup.2, R.sup.3 and R.sup.4 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphanoyl or halogen, and X represents a tertiary amino group -NR.sup.5, R.sup.6, wherein R.sup.5 and R.sup.6 signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and which may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers, their use as drugs, especially as anticholinergic agents, their use for preparing an anticholinergic drug, pharmaceutical compositions containing the novel amines, and methods for preparing the same.
    Patent expiration dates:

    • March 25, 2012


    • September 25, 2012
      ✓ 
      Pediatric exclusivity




  • Pharmaceutical formulation and its use
    Patent 6,630,162
    Issued: October 7, 2003
    Inventor(s): Lisbeth; Nilvebrant & Bengt; Hallen & Birgitta; Olsson & Jan; Strombom & Torkek; Gren & Anders; Ringberg & Martin; Wikberg
    Assignee(s): Pharmacia AB
    The invention relates to a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the formulation exhibits a controlled in vitro release of the active ingredient in phosphate buffer at pH 6.8 of not less than about 80% after 18 hours, and after oral administration to a patient is capable of maintaining a substantially constant serum level of the active moiety or moieties for 24 hours. The invention also relates to the use of the pharmaceutical formulation for treating overactive bladder and gastrointestinal disorders.
    Patent expiration dates:

    • November 11, 2019
      ✓ 
      Patent use: TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE.
      ✓ 
      Drug product


    • May 11, 2020
      ✓ 
      Pediatric exclusivity




  • Therapeutic formulation for administering tolterodine with controlled release
    Patent 6,770,295
    Issued: August 3, 2004
    Inventor(s): Bo; Kreilgård & Lene; Orup Jacobsen & Ulla; Hoeck & Helle; Kristensen & Torkel; Gren & Lisbeth; Nilvebrant & Anders; Ringberg & Martin; Wikberg & Bengt; Hallén & Birgitta; Olsson & Jan; Strömbom
    Assignee(s): Pharmacia AB
    The present invention is drawn to a method of treating an unstable or overactive urinary bladder by treating the patient with tolterodine or a tolterodine-related compound, or pharmaceutically acceptable salt thereof, with a controlled release formulation that maintains a substantially constant serum level of the active moiety or moieties for at least 24 hours. The present invention is further drawn to a formulation for the method.
    Patent expiration dates:

    • August 26, 2019
      ✓ 
      Patent use: TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE.
      ✓ 
      Drug product


    • February 26, 2020
      ✓ 
      Pediatric exclusivity




  • Controlled release bead, a method of producing the same and multiple unit formulation comprising it
    Patent 6,911,217
    Issued: June 28, 2005
    Inventor(s): Gren; Torkel & Ringberg; Anders & Wikberg; Martin & Wald; Randy J.
    Assignee(s): Pharmacia AB
    A controlled release bead comprises: (i) a core unit of a substantially water-soluble or water-swellable inert material; (ii) a first layer on the core unit of a substantially water-insoluble polymer; (iii) a second layer covering the first layer and containing an active ingredient; and (iv) a third layer of polymer on the second layer effective for controlled release of the active ingredient, wherein the first layer is adapted to control water penetration into the core. A method of producing the controlled release bead is also disclosed.
    Patent expiration dates:

    • August 26, 2019
      ✓ 
      Patent use: TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE.
      ✓ 
      Drug product


    • February 26, 2020
      ✓ 
      Patent use: TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE.
      ✓ 
      Pediatric exclusivity
      ✓ 
      Drug product



See also...

  • Detrol LA Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Detrol LA Consumer Information (Cerner Multum)
  • Detrol LA Advanced Consumer Information (Micromedex)
  • Tolterodine Consumer Information (Wolters Kluwer)
  • Tolterodine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Tolterodine Consumer Information (Cerner Multum)
  • Tolterodine Advanced Consumer Information (Micromedex)
  • Tolterodine Tartrate AHFS DI Monographs (ASHP)

Thursday, 14 October 2010

Cortizone for Kids




In the US, Cortizone for Kids (hydrocortisone topical) is a member of the drug class topical steroids and is used to treat Anal Itching, Aphthous Stomatitis - Recurrent, Atopic Dermatitis, Dermatitis, Eczema, Gingivitis, Proctitis, Pruritus, Psoriasis, Seborrheic Dermatitis and Skin Rash.

US matches:

  • Cortizone for Kids

Ingredient matches for Cortizone for Kids



Hydrocortisone

Hydrocortisone is reported as an ingredient of Cortizone for Kids in the following countries:


  • United States

International Drug Name Search

Tuesday, 12 October 2010

Suppositoria Glycerini Galvex




Suppositoria Glycerini Galvex may be available in the countries listed below.


Ingredient matches for Suppositoria Glycerini Galvex



Glycerol

Glycerol is reported as an ingredient of Suppositoria Glycerini Galvex in the following countries:


  • Slovakia

International Drug Name Search

Tuesday, 28 September 2010

Deltalaf




Deltalaf may be available in the countries listed below.


Ingredient matches for Deltalaf



Betamethasone

Betamethasone is reported as an ingredient of Deltalaf in the following countries:


  • Argentina

International Drug Name Search

Monday, 27 September 2010

Statrol




In the US, Statrol (neomycin/polymyxin b ophthalmic).

US matches:

  • Statrol

  • Statrol Ophthalmic Solution

Ingredient matches for Statrol



Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Statrol in the following countries:


  • Belgium

Polymyxin B

Polymyxin B sulfate (a derivative of Polymyxin B) is reported as an ingredient of Statrol in the following countries:


  • Belgium

International Drug Name Search

Anisto




Anisto may be available in the countries listed below.


Ingredient matches for Anisto



Carvedilol

Carvedilol is reported as an ingredient of Anisto in the following countries:


  • Japan

International Drug Name Search

Friday, 24 September 2010

Apo-Feno-Micro




Apo-Feno-Micro may be available in the countries listed below.


Ingredient matches for Apo-Feno-Micro



Fenofibrate

Fenofibrate is reported as an ingredient of Apo-Feno-Micro in the following countries:


  • Canada

International Drug Name Search

Monday, 20 September 2010

Bio-Nifedipine




Bio-Nifedipine may be available in the countries listed below.


Ingredient matches for Bio-Nifedipine



Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Bio-Nifedipine in the following countries:


  • South Africa

International Drug Name Search

Sunday, 19 September 2010

Kinestat




Kinestat may be available in the countries listed below.


Ingredient matches for Kinestat



Epalrestat

Epalrestat is reported as an ingredient of Kinestat in the following countries:


  • Japan

International Drug Name Search

Friday, 17 September 2010

Tolma




Tolma may be available in the countries listed below.


Ingredient matches for Tolma



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tolma in the following countries:


  • Philippines

International Drug Name Search

Tuesday, 14 September 2010

Lomedil




Lomedil may be available in the countries listed below.


Ingredient matches for Lomedil



Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Lomedil in the following countries:


  • Taiwan

International Drug Name Search

Monday, 13 September 2010

Zerlon




Zerlon may be available in the countries listed below.


Ingredient matches for Zerlon



Finasteride

Finasteride is reported as an ingredient of Zerlon in the following countries:


  • Serbia

International Drug Name Search

Phentermine Quality




Phentermine Quality may be available in the countries listed below.


Ingredient matches for Phentermine Quality



Phentermine

Phentermine hydrochloride (a derivative of Phentermine) is reported as an ingredient of Phentermine Quality in the following countries:


  • Hong Kong

International Drug Name Search

Saturday, 11 September 2010

Promethazine hydrochloride and Phenylephrine hydrochloride




Ingredient matches for Promethazine hydrochloride and Phenylephrine hydrochloride



Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Promethazine hydrochloride and Phenylephrine hydrochloride in the following countries:


  • United States

Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Promethazine hydrochloride and Phenylephrine hydrochloride in the following countries:


  • United States

International Drug Name Search

Wednesday, 1 September 2010

Clopramide




Clopramide may be available in the countries listed below.


Ingredient matches for Clopramide



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Clopramide in the following countries:


  • Algeria

International Drug Name Search

Sunday, 22 August 2010

Piroxicam Domesco




Piroxicam Domesco may be available in the countries listed below.


Ingredient matches for Piroxicam Domesco



Piroxicam

Piroxicam is reported as an ingredient of Piroxicam Domesco in the following countries:


  • Vietnam

International Drug Name Search

Pexsig




Pexsig may be available in the countries listed below.


Ingredient matches for Pexsig



Perhexiline

Perhexiline maleate (a derivative of Perhexiline) is reported as an ingredient of Pexsig in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Saturday, 21 August 2010

Diltiazem




In some countries, this medicine may only be approved for veterinary use.


In the US, Diltiazem (diltiazem systemic) is a member of the following drug classes: calcium channel blocking agents, group IV antiarrhythmics and is used to treat Angina Pectoris Prophylaxis, Atrial Fibrillation, Atrial Flutter, Heart Failure, High Blood Pressure, Raynaud's Syndrome and Supraventricular Tachycardia.

US matches:

  • Diltiazem

  • Diltiazem 12-Hour Sustained-Release Capsules

  • Diltiazem 24-Hour Extended-Release Beads Capsules

  • Diltiazem 24-Hour Extended-Release Beads Tablets

  • Diltiazem 24-Hour Sustained-Release Beads Capsules

  • Diltiazem 24-Hour Sustained-Release Capsules

  • Diltiazem Immediate-Release Tablets

  • Diltiazem Hydrochloride CD

  • Diltiazem Hydrochloride SR

  • Diltiazem Hydrochloride XR

  • Diltiazem Hydrochloride XT

  • Diltiazem and enalapril

  • Diltiazem y enalapril

  • Diltiazem Intravenous

  • Diltiazem Hydrochloride

  • Diltiazem Injection

  • Diltiazem Tablets

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C08DB01

CAS registry number (Chemical Abstracts Service)

0042399-41-7

Chemical Formula

C22-H26-N2-O4-S

Molecular Weight

414

Therapeutic Categories

Coronary vasodilator

Calcium channel blocker

Chemical Name

1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-

Foreign Names

  • Diltiazemum (Latin)
  • Diltiazem (German)
  • Diltiazem (French)
  • Diltiazem (Spanish)

Generic Names

  • Diltiazem (OS: BAN, DCIT, DCF)
  • Defemerin (IS)
  • Diltiazem Hydrochloride (OS: JAN, USAN, BANM)
  • CRD 401 (IS: Tanabe)
  • Diltiazem (chlorhydrate de) (PH: Ph. Eur. 6)
  • Diltiazem Hydrochloride (PH: BP 2010, JP XV, USP 32, Ph. Eur. 6)
  • Diltiazemhydrochlorid (PH: Ph. Eur. 6)
  • Diltiazemi hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • Alandiem
    Zimaia, Portugal


  • Aldizem
    Alkaloid, Bosnia & Herzegowina; Alkaloid, Bulgaria; Alkaloid, Croatia (Hrvatska); Alkaloid, Slovenia


  • Altiazem RR
    Berlin-Chemie, Lithuania


  • Altiazem
    Lusofarmaco, Tunisia


  • Bi-Tildiem
    Sanofi, Tunisia


  • Cal-Antagon
    Ferring, Portugal


  • Cordizem
    Kimia Farma, Indonesia


  • Dilcontin
    Modi-Mundipharma, India; Modi-Mundipharma, Sri Lanka


  • Dilgard
    Cipla, Peru


  • Dilmacor
    Magistra, Romania


  • DiltaHexal
    Hexal, Luxembourg


  • Dilta-Hexal
    Hexal, Luxembourg


  • Diltam
    Rowa, Peru


  • Diltiangina
    Tecnimede, Portugal


  • Diltiax
    Ethical, Dominican Republic


  • Diltiazem 90 Retard
    Actavis, Georgia


  • Diltiazem Genfar
    Genfar, Colombia; Genfar, Ecuador; Genfar, Peru


  • Diltiazem La Santé
    La Santé, Colombia


  • Diltiazem Lannacher
    Lannacher, Estonia; Lannacher, Lithuania


  • Diltiazem LPH
    Labormed Pharma, Romania


  • Diltiazem
    Actavis, Georgia; Farmindustria, Peru; Infarmasa, Peru; LCG, Peru


  • Dilzen-G
    Klonal, Argentina


  • Dipen
    Elpen, Tunisia


  • Dodexen
    Roemmers, Peru


  • DTM
    Biochem, India


  • Entrydil
    Orion, Ireland


  • Fada Diltiazem
    Fada, Argentina


  • Hypercard (veterinary use)
    Arnolds, Luxembourg; Arnolds, Portugal


  • Incoril
    Bagó, Ecuador


  • Iski
    Stadmed, India


  • Mono-Tildiem
    Sanofi Aventis, Tunisia


  • Progor
    UIC/Giant, Taiwan


  • Tildiem
    ADWYA, Tunisia; Chemopharma, Chile; Sanofi Aventis, Tunisia


  • Umezar
    Apotecarium, Colombia


  • Acalix
    Roemmers, Argentina; Vargas, Venezuela


  • Acasmul
    Pharma Investi, Chile


  • Adco-Zildem
    Adcock Ingram Pharmaceuticals, South Africa


  • Adizem CD
    Rafa, Israel


  • Adizem XL
    Mundipharma, Ireland


  • Adizem
    Mundipharma, Bahrain; Mundipharma, Ireland; Napp, United Kingdom


  • Altiazem
    Berlin-Chemie, Bulgaria; Berlin-Chemie, Russian Federation; Lusofarmaco, Estonia; Lusofarmaco, Italy; Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Latvia; Menarini, Panama; Menarini, El Salvador


  • Altizem
    Nobel, Bosnia & Herzegowina; Nobel, Turkey


  • Angiazem
    Galenika, Serbia


  • Angiodrox
    Solvay, Spain


  • Angiolong
    Farmalab, Brazil


  • Angiotrofin
    Armstrong, Costa Rica; Armstrong, Dominican Republic; Armstrong, Guatemala; Armstrong, Honduras; Armstrong, Mexico; Armstrong, Nicaragua; Armstrong, Panama; Armstrong, El Salvador


  • Angiozem
    Littman, Philippines


  • Angitil
    Trinity-Chiesi, United Kingdom


  • Angizem
    Sanofi-Aventis, Italy; Sun, Sri Lanka; Sun, Myanmar


  • Apo-Diltiaz
    Apotex, Canada; Apotex, Vietnam


  • Balcor
    Baldacci, Brazil


  • Beatizem
    Beacons, Singapore


  • Bi-Tildiem
    Sanofi-Aventis, Bahrain; Sanofi-Aventis, France; Sanofi-Aventis, Oman


  • Blocalcin
    Lachema, Czech Republic; Pliva, Hungary; Pliva, Slovakia; Pliva Lachema, Poland


  • Calnurs
    Nippon Chemiphar, Japan


  • Cardil
    Ibn Sina, Bangladesh; Orion, United Arab Emirates; Orion, Bahrain; Orion, Denmark; Orion, Egypt; Orion, Georgia; Orion, Jordan; Orion, Kuwait; Orion, Lebanon; Orion, Lithuania; Orion, Qatar; Orion, Russian Federation; Orion, Singapore; Orion, Thailand; Orion, Yemen; Santa, Greece


  • Cardiser
    Merck, Spain


  • Cardium
    DHA, Singapore


  • Cardizem CD
    Biovail, Canada


  • Cardizem Retard
    Ferrosan, Iceland; Pfizer, Norway; Pfizer, Taiwan


  • Cardizem Uno
    Pfizer, Norway


  • Cardizem Unotard
    Pfizer, Sweden; Pfizer, Taiwan


  • Cardizem
    Aventis, New Zealand; Biovail, Canada; Biovail, United States; Boehringer Ingelheim, Brazil; Drug International, Bangladesh; Ferrosan, Denmark; Ferrosan, Iceland; Kos, United States; Pfizer, Finland; Pfizer, Sweden; Sanofi-Aventis, Australia


  • Cardizem Retard
    Pfizer, Sweden


  • Carreldon
    Bama-Geve, Spain


  • Cartia XT
    Andrx, United States


  • Cartia
    Watson, United States


  • Channel
    Micro Labs, Sri Lanka


  • Chlorhydrate de Diltiazem Mylan
    Mylan, France


  • Clarute R
    Sawai Seiyaku, Japan


  • Clarute
    Sawai Seiyaku, Japan


  • Clobendian
    Efarmes, Spain


  • Cohlen
    Toho Droge, Japan


  • Conductil
    Socobom, Luxembourg


  • Coramil
    Sanofi-Aventis, Sweden


  • Coras
    Alphapharm, Australia


  • Corazem
    Farma, Ecuador; Farma, Venezuela; Grupo Farma, Colombia


  • Cordisil
    Flupal, Venezuela


  • Coridil
    Sandoz, Switzerland


  • Corodrox
    Fabop, Argentina


  • Coroherser R
    Nichi-Iko PharmaceuticalJMA, Japan


  • Coroherser
    Nichi-Iko PharmaceuticalJMA, Japan


  • Corolater
    Sandoz, Spain


  • Cortiazem
    Hemofarm, Serbia


  • Corzem
    Helcor, Romania; United Pharmaceutical, United Arab Emirates; United Pharmaceutical, Bahrain; United Pharmaceutical, Iraq; United Pharmaceutical, Libya; United Pharmaceutical, Qatar; United Pharmaceutical, Saudi Arabia; United Pharmaceutical, Sudan; United Pharmaceutical, Yemen


  • Cronodine
    Alacan, Spain


  • Daltazen GMP
    Giempi, Venezuela


  • Dasav
    Victory, Mexico


  • Dazil
    Aegis, Malta


  • Deltazen LP
    Sanofi-Aventis, France


  • Denazox
    Remedica, Cyprus; Remedica, Malta


  • Diacor LP
    Dexo, France


  • Diacor
    Dexo, France


  • Diacordin
    Zentiva, Czech Republic; Zentiva, Poland; Zentiva, Romania; Zentiva, Slovakia


  • Dial
    Nipa, Bangladesh


  • Diazem
    Medochemie, Russian Federation


  • Dilaclan
    Q-Pharma, Spain


  • Dilacor XR
    Watson, United States


  • Diladel
    Sanofi-Aventis, Italy


  • Dilatam
    Abic, Israel; Teva, Latvia


  • Dilcardia
    Unique, India; Unique, Sri Lanka


  • Dilcontin Continus
    Modi-Mundipharma, Bangladesh; Modi-Mundipharma, Bangladesh


  • Dilcontin
    Modi-Mundipharma, Bangladesh


  • Dilcor
    Gross, Brazil; Norpharma, Denmark


  • Dilem
    Istituto Chim. Internazionale, Italy


  • Dilfar
    Solvay, Portugal


  • Dilgina
    Kopran, Sri Lanka


  • Diliter
    B&G, Italy


  • Dilmen
    Sanbe, Indonesia


  • Dilocard
    ICN, Poland


  • Dilrène LP
    Sanofi-Aventis, France


  • Dilrene
    Sanofi-Aventis, Hungary


  • Dilrène
    Sanofi-Aventis, France


  • Dilsal
    TAD, Germany


  • Dil-Sanorania
    Winthrop, Germany


  • DiltaHexal
    Hexal, Germany; Sandoz, Australia


  • Diltam
    Rowex, Ireland


  • Diltaretard
    Betapharm, Germany


  • Dilt-CD
    Apotex, United States


  • Diltelan
    Elan, Taiwan; Faran Laboratories, Greece; OEP, Philippines


  • Diltenk
    Biotenk, Argentina


  • Dilti SR
    Edruc, Bangladesh


  • Diltia XT
    Andrx, United States; Watson, United States


  • Diltiagamma
    Wörwag Pharma, Germany


  • Diltiastad retard
    Stada, Austria


  • Diltiasyn
    Sanofi-Aventis, Colombia


  • Diltiazem AbZ
    AbZ, Germany


  • Diltiazem AccordHealthcare
    Accord Healthcare, Netherlands


  • Diltiazem Actavis
    Balkanpharma, Bulgaria


  • Diltiazem AL
    Aliud, Germany


  • Diltiazem Alter
    Alter, Spain


  • Diltiazem Biogaran
    Biogaran, France


  • Diltiazem Clorhidrato Genfar
    Expofarma, Chile


  • Diltiazem CristerS
    CristerS, France


  • Diltiazem DOC
    DOC Generici, Italy


  • Diltiazem Dorom
    Dorom, Italy


  • Diltiazem Edigen
    Edigen, Spain


  • Diltiazem EG
    EG, Italy; EG Labo, France


  • Diltiazem Euderma
    Genepharm, Greece


  • Diltiazem Farmoz
    Farmoz, Portugal


  • Diltiazem Genericon retard
    Genericon, Austria


  • Diltiazem HCl A
    Apothecon, Netherlands


  • Diltiazem HCl Actavis
    Actavis, Netherlands


  • Diltiazem HCl CF
    Centrafarm, Netherlands


  • Diltiazem HCl Katwijk
    Apotex Europe, Netherlands


  • Diltiazem HCl Merck
    Mylan, Netherlands


  • Diltiazem HCl PCH
    Pharmachemie, Netherlands


  • Diltiazem HCl ratiopharm
    ratiopharm, Netherlands


  • Diltiazem HCl Sandoz
    Sandoz, Netherlands


  • Diltiazem HCl
    Sanofi-Aventis, Netherlands


  • Diltiazem Hennig
    Hennig, Germany


  • Diltiazem Heumann
    Heumann, Germany


  • Diltiazem Hydrochloride
    Actavis, United States; Apotex, United States; Baxter, United States; Bedford, United States; Biovail, United States; Dava, United States; Hospira, United States; International Medication Systems, United States; KV Pharmaceutical, United States; Mylan, United States; Teva USA, United States; Torpharm, United States; UDL, United States; Watson, United States


  • Diltiazem Lannacher
    Lannacher, Latvia; Lannacher, Russian Federation


  • Diltiazem Merck
    Merck Genéricos, Portugal


  • Diltiazem Mundogen
    Mundogen, Spain


  • Diltiazem Mylan
    Mylan, France; Mylan, Italy


  • Diltiazem Northia
    Northia, Argentina


  • Diltiazem Pensa
    Pensa, Italy; Pensa Pharma, Spain


  • Diltiazem Pliva
    Pliva, Estonia; Pliva, Croatia (Hrvatska)


  • Diltiazem Ranbaxy
    Ranbaxy, Spain


  • Diltiazem ratiopharm retard
    Ratiopharm, Austria


  • Diltiazem ratiopharm
    Ratiopharm, Austria; Ratiopharm, Belgium; Ratiopharm, France; Ratiopharm, Italy


  • Diltiazem ret-1A Pharma
    1A Pharma, Germany


  • Diltiazem RPG
    Ranbaxy, France


  • Diltiazem Sandoz
    Sandoz, Spain; Sandoz, France; Sandoz, Italy


  • Diltiazem Siga
    Sigapharm, Germany


  • Diltiazem Sopharma
    Sopharma, Bulgaria


  • Diltiazem Stada
    Stada, Germany; Stada, Spain


  • Diltiazem Teva
    Teva, Belgium; Teva, Georgia; Teva, Italy; Teva, Latvia; Teva Santé, France


  • Diltiazem Verla
    Verla, Germany


  • Diltiazem
    Actavis, United Kingdom; Alkaloid, Serbia; Arena, Romania; E.I.P.I.C.O., Romania; Medicalex, Colombia; Pentacoop, Colombia; Polfarmex, Poland; Slaviamed, Serbia; Terapia, Romania


  • Diltiazemhydrochloride
    Wise, Netherlands


  • Diltiazem-Mepha
    Mepha Pharma, Switzerland


  • Diltiazem-ratiopharm
    Ratiopharm, Germany; Ratiopharm, Russian Federation


  • Diltiazem-Tchaikapharma
    Tchaikapharma, Bulgaria


  • Diltiazem-Xl
    Pharmatec, Luxembourg


  • Dilti-CT
    CT Arzneimittel, Germany


  • Diltiem
    Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal


  • Diltiwas
    Chiesi, Spain


  • Diltizem/Diltizem SR
    Mustafa Nevzat, Turkey; Square, Bangladesh


  • Diltizem
    Pfizer, Brazil; Square, Sri Lanka


  • Diltor
    Torrent, Brazil


  • Diltzac
    Apotex, United States


  • Dilzacard
    Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Oman; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Yemen


  • Dilzem Parenteral
    Parke Davis, Bulgaria; Pfizer, Romania


  • Dilzem XL
    Cephalon, Ireland


  • Dilzem
    Cephalon, United Kingdom; Douglas, New Zealand; Genepharm, Australia; Gödecke, Germany; Gödecke, Poland; Orion, Finland; Pfizer, Bahrain; Pfizer, Switzerland; Pfizer, Hungary; Pfizer, Lithuania; Pfizer, Latvia; Pfizer, Oman; Pfizer, Philippines; Pfizer, Romania; Torrent, India


  • Dilzene
    Sigma Tau, Italy


  • Dinisor
    Parke Davis, Spain


  • Dipen
    Elpen, Greece


  • Doclis
    Bial, Spain


  • Elvesil
    Biomedica-Chemica, Greece


  • Ergoclavin
    Bros, Greece


  • Ergolan
    Ethypharm, China


  • Etizem
    Neo-Farmacêutica, Portugal


  • Etyzem
    Actavis, Italy


  • Evascon
    Renata, Bangladesh


  • Frotty
    Nagase Iyakuhin, Japan


  • Gen-Diltiazem
    Genpharm, Canada


  • GenRX Diltiazem
    Apotex, Australia


  • Grifodilzem
    Chile, Chile


  • Hart
    Ivax, Argentina


  • Hemarekeat
    Tsuruhara Seiyaku, Japan


  • Herbesser
    Delta, Portugal; Fournier, Singapore; Tanabe, Indonesia; Tanabe, Taiwan; Tanabe Mitsubishi, Japan; Tanabe Seiyaku, Bangladesh; Tanabe Seiyaku, Hong Kong; Tanabe Seiyaku, Sri Lanka; Tanabe Seiyaku, Myanmar; Tanabe Seiyaku, Malaysia; Tanabe Seiyaku, Thailand


  • Herbesser R
    Solvay, Singapore; Tanabe Mitsubishi, Japan


  • Hesor
    Yu Sheng, Taiwan


  • Hirosutas R
    Daito, Japan


  • Incoril A.P.
    Bago, Chile


  • Incoril
    Bago, Chile; Bago, Peru; Bagó, Argentina


  • Kaizem CD
    Wockhardt, India


  • Kaltiazem
    Fabra, Argentina


  • Korzem
    Actavis, Iceland


  • Lacerol Hta
    Lacer, Spain


  • Lacerol
    Lacer, Dominican Republic; Lacer, Spain; Lacer, Guatemala; Lacer, Honduras; Lacer, Nicaragua; Lacer, El Salvador


  • Lanodil
    Landson, Indonesia


  • Levodex
    Dexxon, Israel


  • Litizem
    Incepta, Bangladesh


  • Longazem
    De Salute, Italy


  • Lutianon R
    Sato Seiyaku, Japan


  • Marumunen
    Zensei Yakuhin, Japan


  • Masdil
    Laboratorios Dr Esteve, Spain


  • Mavitalon
    Help, Greece


  • Miocardie
    Nisshin Seiyaku - Yamagata, Japan


  • Mono Tildiem
    Sanofi-Aventis, France


  • Mono-Tildiem
    Sanofi-Aventis, France; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Oman; Sanofi-Aventis, Singapore; Sanofi-Synthelabo, Luxembourg


  • Myonil
    Ferrosan, Denmark


  • Nackless
    Kyowa Yakuhin, Japan


  • Nackless L
    Kyowa Yakuhin, Japan


  • Neocard
    Beximco, Bangladesh


  • Novo-Diltazem
    Novopharm, Canada


  • Nu-Diltiaz
    Nu-Pharm, Canada


  • Oxycardil
    Schwarz, Poland


  • Paretnamin
    Taisho Yakuhin, Japan


  • Pazeadin
    Taiyo Pharmaceutical, Japan


  • Pazeadin R
    Taiyo Pharmaceutical, Japan


  • Presoquin
    Dollder, Venezuela


  • Progor
    SMB, Belgium; SMB, Luxembourg


  • ratio-Diltiazem
    ratiopharm, Canada


  • Riazem
    Riyad Pharma, Oman


  • Ritemed Diltiazem HCl
    Ritemed, Philippines


  • Rozen
    Rowe, Dominican Republic


  • Rubiten
    Rafarm, Greece


  • Sandoz Diltiazem
    Sandoz, Canada


  • Seresnatt
    Towa Yakuhin, Japan


  • Slozem
    Merck Serono, United Kingdom


  • Surazem
    Pharmacia, Luxembourg


  • Taztia
    Watson, United States


  • Ternel
    Chrispa, Greece


  • Tiadil
    Basi, Portugal


  • Tiazac
    Biovail, Canada; Biovail, United States; Forest, United States


  • Tiazem
    Hilton, Sri Lanka


  • Tilazem
    Elea, Argentina; Pfizer, Belize; Pfizer, Chile; Pfizer, Colombia; Pfizer, Costa Rica; Pfizer, Ecuador; Pfizer, Guatemala; Pfizer, Honduras; Pfizer, Nicaragua; Pfizer, Panama; Pfizer, Peru; Pfizer, El Salvador; Pfizer, Venezuela; Pfizer, South Africa


  • Tildiem
    Delphi, Netherlands; Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Eureco, Netherlands; Euro, Netherlands; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Ireland; Sanofi-Aventis, Italy; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Oman; Sanofi-Aventis, Vietnam; Sanofi-Synthelabo, Greece; Sanofi-Synthelabo, Luxembourg


  • Tilhasan
    Hasan, Vietnam


  • Tilker Gervasi
    Gervasi, Spain


  • Tilker
    Sanofi-Aventis, Denmark; Sanofi-Aventis S.A., Spain


  • Tizem
    Delta, Bangladesh


  • Trumsal
    Centrum, Spain


  • Uni Masdil
    Laboratorios Dr Esteve, Spain


  • Vasocardol
    Sanofi-Aventis, Australia


  • Viazem
    Biovail, Luxembourg; Genus, United Kingdom


  • Youtiazem
    Yoshindo, Japan


  • Zandil
    Therapharma, Philippines


  • Zem
    Faran Laboratories, Greece


  • Zemtard
    Galen, United Kingdom


  • Zildem
    Adcock Ingram Pharmaceuticals, South Africa


  • Zilden Genepharm
    Genepharm, Greece


  • Ziruvate
    Choseido Pharmaceutical, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 17 August 2010

Carbamazepin Sandoz




Carbamazepin Sandoz may be available in the countries listed below.


Ingredient matches for Carbamazepin Sandoz



Carbamazepine

Carbamazepine is reported as an ingredient of Carbamazepin Sandoz in the following countries:


  • Germany

International Drug Name Search

Sunday, 15 August 2010

Nebupent


Nebupent is a brand name of pentamidine, approved by the FDA in the following formulation(s):


NEBUPENT (pentamidine isethionate - for solution; inhalation)



  • Manufacturer: APP PHARMS

    Approval date: June 15, 1989

    Strength(s): 300MG/VIAL [RLD]

Has a generic version of Nebupent been approved?


No. There is currently no therapeutically equivalent version of Nebupent available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nebupent. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Nebupent.

See also...

  • Nebupent Solution Consumer Information (Wolters Kluwer)
  • Nebupent Consumer Information (Cerner Multum)
  • Nebupent Advanced Consumer Information (Micromedex)
  • Pentamidine Consumer Information (Wolters Kluwer)
  • Pentamidine Solution Consumer Information (Wolters Kluwer)
  • Pentamidine Consumer Information (Cerner Multum)
  • Pentamidine Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
  • Pentamidine Injection Advanced Consumer Information (Micromedex)
  • Pentamidine Isethionate AHFS DI Monographs (ASHP)

Angiodrox




Angiodrox may be available in the countries listed below.


Ingredient matches for Angiodrox



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Angiodrox in the following countries:


  • Spain

International Drug Name Search

Dermovate


Generic Name: clobetasol (Topical application route)


kloe-BAY-ta-sol PROE-pee-oh-nate


Commonly used brand name(s)

In the U.S.


  • Clobevate

  • Clobex

  • Cormax

  • Embeline

  • Embeline E

  • Embeline Scalp Application

  • Olux

  • Olux/Olux-E Complete Pack

  • Olux-E

  • Temovate

  • Temovate E

In Canada


  • Clobetasol Propionate

  • Dermovate

  • Dermovate Scalp Application

  • Med Clobetasol Scalp Application

  • Ratio-Clobetasol

Available Dosage Forms:


  • Cream

  • Ointment

  • Gel/Jelly

  • Spray

  • Solution

  • Foam

  • Emollient Cream

  • Lotion

  • Shampoo

Therapeutic Class: Corticosteroid, Very Strong


Pharmacologic Class: Clobetasol


Uses For Dermovate


Clobetasol topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. The solution and foam are used for scalp problems, the lotion and spray are used for moderate to severe plaque psoriasis, and the shampoo is used for moderate to severe scalp psoriasis. This medicine is a corticosteroid (cortisone-like medicine or steroid).


This medicine is available only with your doctor's prescription.


Before Using Dermovate


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of clobetasol topical gel, foam, cream, ointment, or scalp solution in children 12 years of age and older. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. Safety and efficacy have not been established in children younger than 12 years of age and the use of clobetasol topical gel, foam, cream, ointment, or scalp solution is not recommended. The safety and efficacy of clobetasol topical spray, lotion, or shampoo have not been established in children and use is not recommended.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of clobetasol topical in the elderly.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cushing's syndrome (adrenal gland disorder) or

  • Diabetes or

  • Hyperglycemia (high blood sugar) or

  • Intracranial hypertension (increased pressure in the head)—Use with caution. May make these conditions worse.

  • Infection of the skin at or near the place of application or

  • Large sores, broken skin, or severe skin injury at the place of application—The chance of side effects may be increased.

  • Perioral dermatitis (skin problem) or

  • Rosacea (skin problem)—Should not be used in patients with these conditions.

Proper Use of clobetasol

This section provides information on the proper use of a number of products that contain clobetasol. It may not be specific to Dermovate. Please read with care.


It is very important that you use this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.


This medicine is for use on the skin only. Do not get it in your eyes, nose, mouth, or vagina. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.


This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present. This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns.


Do not use this medicine on the face, groin, or underarms unless directed to do so by your doctor.


To use the cream, foam, gel, lotion, ointment, or spray:


  • Wash your hands with soap and water before and after using this medicine.

  • Apply a thin layer of this medicine to the affected area of the skin. Rub it in gently.

  • With the lotion, protect the skin from water, clothing, or anything that causes rubbing until the medicine has dried. Also, shake the lotion well before using it.

  • Do not bandage or otherwise wrap the skin being treated unless directed to do so by your doctor.

To use the foam, scalp solution, or shampoo:


  • Wash your hands with soap and water before and after using this medicine.

  • Apply a thin layer of this medicine to the affected area of the scalp. Rub it in gently.

  • Do not cover the scalp (e.g., shower cap, bathing cap) while it is being treated.

  • Do not use the shampoo for more than 4 weeks, the foam and scalp solution for more than 2 weeks unless your doctor has told you to.

This medicine comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For redness, itching, and swelling of the skin:
    • For topical dosage forms (cream, gel, or ointment):
      • Adults—Apply to the affected area of the skin two times per day.

      • Children 12 to 17 years of age—Apply to the affected area of the skin two times per day.

      • Children younger than 12 years of age—Use is not recommended.


    • For topical dosage form (lotion):
      • Adults—Apply to the affected area of the skin two times per day.

      • Children—Use is not recommended.



  • For plaque psoriasis:
    • For topical dosage form (foam):
      • Adults—Apply to the affected area of the skin two times per day, once in the morning and once at night.

      • Children 12 to 17 years of age—Apply to the affected area of the skin two times per day, once in the morning and once at night.

      • Children younger than 12 years of age—Use is not recommended.


    • For topical dosage form (spray):
      • Adults—Spray to the affected area of the skin two times per day.

      • Children—Use is not recommended.



  • For scalp problems:
    • For topical dosage form (foam or scalp solution):
      • Adults—Apply to the affected area of the scalp two times per day, once in the morning and once at night.

      • Children 12 to 17 years of age—Apply to the affected area of the scalp two times per day, once in the morning and once at night.

      • Children younger than 12 years of age—Use is not recommended.


    • For topical dosage form (shampoo):
      • Adults—Apply to the affected area of the scalp once a day.

      • Children—Use is not recommended.



Missed Dose


If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Store the foam can at room temperature, away from heat and direct light. Do not keep this medicine inside a car where it could be exposed to extreme heat. Do not poke holes in the canister or throw it into a fire, even if the canister is empty.


Precautions While Using Dermovate


It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by this medicine.


If your or your child's symptoms do not improve within a few days, or if they become worse, check with your doctor.


Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.


Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.


Make sure your doctor knows that you are using clobetasol gel. You may need to stop using this medicine several days before having surgery.


Do not use cosmetics or other skin care products on the treated areas.


Dermovate Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Burning or stinging at the application site

Less common
  • Burning sensation of the skin

  • dry skin

  • flushing or redness of the skin

  • itching, scaling, severe redness, soreness, or swelling of the skin

  • skin irritation

  • skin rash, encrusted, scaly and oozing

  • thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (e.g. between the fingers)

Incidence not known
  • Burning, itching, and pain in hairy areas, or pus at the root of the hair

  • hair loss

  • redness and scaling around the mouth

  • thinning of the hair

  • thinning, weakness, or wasting away of the skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Cough

  • sore throat

Less common
  • Burning, itching, and pain in hairy areas, or pus at the root of the hair

  • changes in skin coloring

  • body aches or pain

  • congestion

  • cough

  • dryness or soreness of the throat

  • fever

  • headache

  • hoarseness

  • raised, dark red, wart-like spots on the skin, especially when used on the face

  • skin discomfort

  • stuffy or runny nose

  • tender, swollen glands in the neck

  • trouble with swallowing

  • unusual tiredness or weakness

  • voice changes

Incidence not known
  • Acne or pimples

  • burning and itching of the skin with pinhead-sized red blisters

  • increased hair growth on the forehead, back, arms, and legs

  • lightening of normal skin color

  • lightening of treated areas of dark skin

  • reddish purple lines on the arms, face, legs, trunk, or groin

  • softening of the skin

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Dermovate side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Dermovate resources


  • Dermovate Side Effects (in more detail)
  • Dermovate Use in Pregnancy & Breastfeeding
  • Dermovate Drug Interactions
  • Dermovate Support Group
  • 0 Reviews for Dermovate - Add your own review/rating


Compare Dermovate with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Lichen Planus
  • Lichen Sclerosus
  • Psoriasis

Friday, 13 August 2010

Zaxine




Zaxine may be available in the countries listed below.


Ingredient matches for Zaxine



Rifaximin

Rifaximin is reported as an ingredient of Zaxine in the following countries:


  • Spain

International Drug Name Search

Tuesday, 10 August 2010

Listril




Listril may be available in the countries listed below.


Ingredient matches for Listril



Lisinopril

Lisinopril is reported as an ingredient of Listril in the following countries:


  • Bahrain

  • Brazil

  • Russian Federation

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Listril in the following countries:


  • Vietnam

International Drug Name Search

Stesolid novum




Stesolid novum may be available in the countries listed below.


Ingredient matches for Stesolid novum



Diazepam

Diazepam is reported as an ingredient of Stesolid novum in the following countries:


  • Iceland

  • Sweden

International Drug Name Search

Monday, 9 August 2010

Citalopram Tiefenbacher




Citalopram Tiefenbacher may be available in the countries listed below.


Ingredient matches for Citalopram Tiefenbacher



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram Tiefenbacher in the following countries:


  • Netherlands

International Drug Name Search

Thursday, 5 August 2010

Lovastatina Edigen




Lovastatina Edigen may be available in the countries listed below.


Ingredient matches for Lovastatina Edigen



Lovastatin

Lovastatin is reported as an ingredient of Lovastatina Edigen in the following countries:


  • Spain

International Drug Name Search

Monday, 2 August 2010

Solu Paraxin




Solu Paraxin may be available in the countries listed below.


Ingredient matches for Solu Paraxin



Chloramphenicol

Chloramphenicol is reported as an ingredient of Solu Paraxin in the following countries:


  • Ethiopia

International Drug Name Search

Sunday, 1 August 2010

Bisoprolol Stada




Bisoprolol Stada may be available in the countries listed below.


Ingredient matches for Bisoprolol Stada



Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol Stada in the following countries:


  • Denmark

  • Finland

  • Germany

  • Sweden

International Drug Name Search

Wednesday, 28 July 2010

Hidroxiurea




Hidroxiurea may be available in the countries listed below.


Ingredient matches for Hidroxiurea



Hydroxycarbamide

Hydroxycarbamide is reported as an ingredient of Hidroxiurea in the following countries:


  • Venezuela

International Drug Name Search

Tuesday, 27 July 2010

Lidoxin




Lidoxin may be available in the countries listed below.


Ingredient matches for Lidoxin



Cloxacillin

Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Lidoxin in the following countries:


  • Singapore

International Drug Name Search

Saver




Saver may be available in the countries listed below.


Ingredient matches for Saver



Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Saver in the following countries:


  • Venezuela

International Drug Name Search

Sunday, 25 July 2010

Medikid




Medikid may be available in the countries listed below.


Ingredient matches for Medikid



Methylphenidate

Methylphenidate hydrochloride (a derivative of Methylphenidate) is reported as an ingredient of Medikid in the following countries:


  • Germany

International Drug Name Search

Friday, 23 July 2010

Implanon


Implanon is a brand name of etonogestrel, approved by the FDA in the following formulation(s):


IMPLANON (etonogestrel - implant; implantation)



  • Manufacturer: ORGANON USA INC

    Approval date: July 17, 2006

    Strength(s): 68MG/IMPLANT [RLD]

Has a generic version of Implanon been approved?


No. There is currently no therapeutically equivalent version of Implanon available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Implanon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Implanon.

See also...

  • Implanon Consumer Information (Drugs.com)
  • Implanon implant Consumer Information (Cerner Multum)
  • Implanon Advanced Consumer Information (Micromedex)
  • Etonogestrel implant Consumer Information (Cerner Multum)
  • Etonogestrel Intradermal Advanced Consumer Information (Micromedex)

Recozil




Recozil may be available in the countries listed below.


Ingredient matches for Recozil



Gemfibrozil

Gemfibrozil is reported as an ingredient of Recozil in the following countries:


  • Singapore

International Drug Name Search

Thursday, 22 July 2010

benzphetamine


Generic Name: benzphetamine (benz FET ah meen)

Brand Names: Didrex


What is benzphetamine?

Benzphetamine is a stimulant that is similar to an amphetamine. Benzphetamine is an appetite suppressant that affects the central nervous system.


Benzphetamine is used togther with diet and exercise to treat obesity (overweight).


Benzphetamine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about benzphetamine?


Benzphetamine can harm an unborn baby or cause birth defects. Do not use benzphetamine if you are pregnant.

Taking benzphetamine together with other diet medications (including medicines available over the counter) can cause a rare fatal lung disorder called pulmonary hypertension. Do not take benzphetamine with any other diet medications without your doctor's advice.


Benzphetamine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Drinking alcohol can increase certain side effects of benzphetamine.

Benzphetamine is only part of a complete program of treatment that may also include diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.


Benzphetamine may be habit-forming and should be used only by the person it was prescribed for. Never share benzphetamine with another person, especially someone with a history of drug abuse or addiction. Keep track of the amount of medicine used from each new bottle. Benzphetamine is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription.

What should I discuss with my healthcare provider before taking benzphetamine?


Do not use benzphetamine if you have taken an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) in the last 14 days. Serious, life threatening side effects can occur if you use benzphetamine before the MAO inhibitor has cleared from your body.

Taking benzphetamine together with other diet medications (including medicines available over the counter) can cause a rare fatal lung disorder called pulmonary hypertension. Do not take benzphetamine with any other diet medications without your doctor's advice.


You should not take benzphetamine if you are allergic to it, or if you have:

  • coronary artery disease (hardening of the arteries);




  • heart disease, heart rhythm disorder;




  • severe or uncontrolled high blood pressure;




  • overactive thyroid;




  • glaucoma;




  • if you are pregnant;




  • if you have a history of drug or alcohol abuse; o




  • if you have used any other diet pills within the past year.



If you have any of these other conditions, you may need a benzphetamine dose adjustment or special tests:



  • high blood pressure;




  • diabetes; or




  • a thyroid disorder.




FDA pregnancy category X. This medication can harm an unborn baby or cause birth defects. Do not use benzphetamine if you are pregnant. Tell your doctor right away if you become pregnant during treatment. Use effective birth control while you are using this medication. Benzphetamine can pass into breast milk and may harm a nursing baby. You should not breast-feed while taking benzphetamine. Do not give this medication to a child younger than 12 years old. Benzphetamine may be habit-forming and should be used only by the person it was prescribed for. Never share benzphetamine with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it.

How should I take benzphetamine?


Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Benzphetamine is usually taken once each day, mid-morning or mid-afternoon.


Talk with your doctor if you have increased hunger or if you otherwise think the medication is not working properly. Taking more of this medication will not make it more effective and can cause serious, life-threatening side effects.

Benzphetamine should be taken only for a short time, such as a few weeks. Tell your doctor if you have not lost any weight after 4 weeks of treatment.


Benzphetamine is only part of a complete program of treatment that may also include diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.


Store at room temperature away from moisture and heat. Keep track of the amount of medicine used from each new bottle. Benzphetamine is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription.

See also: Benzphetamine dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of benzphetamine can be fatal.

Overdose symptoms may include confusion, panic, feeling hostile or aggressive, nausea, vomiting, diarrhea, stomach cramps, fever, muscle pain or weakness, dark colored urine, irregular heartbeat, weak pulse, slow breathing, feeling light-headed, seizure, or fainting.


What should I avoid while taking benzphetamine?


Drinking alcohol can increase certain side effects of benzphetamine.

To prevent sleep problems, avoid taking this medication late in the afternoon.


Benzphetamine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Benzphetamine side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop taking benzphetamine and call your doctor at once if you have a serious side effect such as:

  • feeling short of breath, even with mild exertion;




  • chest pain, feeling like you might pass out;




  • swelling in your ankles or feet;




  • pounding heartbeats or fluttering in your chest;




  • confusion or irritability, unusual thoughts or behavior; or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).



Less serious side effects may include:



  • feeling restless or hyperactive;




  • headache, dizziness, tremors;




  • sleep problems (insomnia);




  • increased sweating;




  • dry mouth or an unpleasant taste in your mouth;




  • nausea, diarrhea upset stomach; or




  • skin rash.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Benzphetamine Dosing Information


Usual Adult Dose for Obesity:

Initial dose: 25 to 50 mg orally once a day in the midmorning or midafternoon

Maintenance dose: 25 to 50 mg orally one to three times a day; dose or frequency should be individualized based on the patient's needs and response

A single daily dose is preferably given in midmorning or midafternoon, according to the patient's eating habits. It may be desirable to avoid late afternoon administration in some patients.


What other drugs will affect benzphetamine?


Tell your doctor about all other medicines you use, especially:



  • ammonium chloride, ascorbic acid (vitamin C), K-Phos;




  • blood pressure medications;




  • insulin or oral diabetes medication;




  • sodium bicarbonate, potassium citrate (K-Lyte, Urocit-K), sodium citrate and citric acid (Bicitra, Oracit), or sodium citrate and potassium (Citrolith, Polycitra);




  • a stimulant or ADHD medication such as amphetamine salt combination (Adderall), dextroamphetamine (Dexedrine), or methylphenidate (Ritalin); or




  • an antidepressant such as amitriptyline (Elavil, Vanatrip), doxepin (Sinequan), desipramine (Norpramin), imipramine (Janimine, Tofranil), nortriptyline (Pamelor), and others.



This list is not complete and other drugs may interact with benzphetamine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More benzphetamine resources


  • Benzphetamine Side Effects (in more detail)
  • Benzphetamine Dosage
  • Benzphetamine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Benzphetamine Drug Interactions
  • Benzphetamine Support Group
  • 5 Reviews for Benzphetamine - Add your own review/rating


  • benzphetamine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benzphetamine Prescribing Information (FDA)

  • Benzphetamine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Didrex Prescribing Information (FDA)

  • Didrex Consumer Overview



Compare benzphetamine with other medications


  • Obesity


Where can I get more information?


  • Your pharmacist can provide more information about benzphetamine.

See also: benzphetamine side effects (in more detail)